Isocitrate dehydrogenase 1(IDH1) mutation in glioma cells leads to an increased level of 24(S)-hydroxycholesterol (24-OHC), which activates liver X receptors (LXRs). This evidence concerns the gene IDH1 and central nervous system cancer.